Alcon Q1 Core Earnings Decline, Sales Rise
Alcon (ALC) Reports Q1 Earnings: What Key Metrics Have to Say
Alcon Cuts FY25 EPS View to $3.05-$3.15 From $3.15-$3.25, Consensus $3.24
Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB
Alcon Q1 Adj. EPS $0.73 Misses $0.75 Estimate, Sales $2.45B Miss $2.51B Estimate
Alcon 1Q Rev $2.47B >ALC.EB
Alcon 1Q EPS 70c >ALC.EB
Press Release: Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery With Unity VCS
Earnings Scheduled For May 13, 2025
Stocks Ex-Dividend May 14
Earnings Preview: Alcon to Report Financial Results Pre-market on May 14
Fund Update: THORNBURG INVESTMENT MANAGEMENT INC Added 249,767 Shares of ALCON ($ALC) to Their Portfolio
RBC Keeps Alcon at Outperform Ahead of Q1 Results
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* With UNITY VCS and UNITY CS
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $120.75
NanoDrops Names Daria Lemann-Blumenthal as CEO
AlphaValue/Baader Europe Upgrades Alcon to Add, Lowers PT
Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk
Alcon To Go Ex-Dividend On May 14th, 2025 With 0.28772 USD Dividend Per Share
Bernstein Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $114.94